$JUNS Jupiter Neurosciences Receives FDA Clearance of IND Application to Initiate Phase 2a Clinical Trial of JOTROL™ in Parkinson’s Disease
https://www.biospace.com/press-releases/jupit...ns-disease
#Stockstobuy #stockstowatch #JUNS #TeamHighAlert @Charles